This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
E. Ansink and J. Wesseler (2009), ‘Quantifying type I and type II errors in decision-making under uncertainty: the case of GM crops’, Letters in Spatial and Resource Sciences 2: 61–66.
A. Apel (2010), ‘The costly benefits of opposing agricultural biotechnology’, New Biotechnology 27: 635–640.
K.J. Arrow and A.C. Fisher (1974), ‘Environmental preservation, uncertainty, and irreversibility’, Quarterly Journal of Economics 88: 312–319.
K. Arrow , M. Cropper, G. Eads, (1996), ‘Is there a role for benefit-cost analysis in environmental, health, and safety regulation?’, Science 272: 221–222.
R. Batista , N. Saibo, T. Lourenco, and M. Oliveira (2008), ‘Microarray analyses reveal that plant mutagenesis may induce more transcriptomic changes than transgene insertion’, Proceedings of the National Academy of Science USA 105: 3640–3645.
M. Baudo , R. Lyons, S. Powers, G. Pastori, K. Edwards, M. Holdsworth, and P. Shewry (2006), ‘Transgenesis has less impact on the transcriptome of wheat grain than conventional breeding’, Plant Biotechnology Journal 4: 369–380.
A.B. Bennett , C. Chi-Ham, G. Barrows, S. Sexton, and D. Zilberman (2013), ‘Agricultural biotechnology: economics, environment, ethics, and the future’, Annual Review of Environment and Resources 38: 19.1–19.31.
A. Case and C. Paxson (2006), ‘Stature and status: height, ability, and labor market outcomes’, Journal of Political Economy 116: 499–532.
J. Currie and R. Hyson (1999), ‘Is the impact of health shocks cushioned by socioeconomic status? The case of low birth weight’, American Economic Review 89: 245–250.
A. Deaton (2003), ‘Health, inequality, and economic development’, Journal of Economic Literature 41: 113–158.
G. Doblhammer and J. Vaupel (2001), ‘Lifespan depends on month of birth’, Proceedings of the National Academy of Sciences USA 98: 2934–2939.
M. Enserink (2008), ‘Tough lessons from Golden Rice’, Science 320: 468–471.
D. Hennessy and G. Moschini (2006), ‘Regulatory actions under adjustment costs and the resolution of scientific uncertainty’, American Journal of Agricultural Economics 88: 308–323.
R. Herman , B. Chassy, and W. Parrott (2009), ‘Compositional assessment of transgenic crops: an idea whose time has passed’, Trends in Biotechnology 27: 555–557.
R. Herring (2007), ‘Opposition to transgenic technologies: ideology, interests and collective action frames’, Nature Review Genetics 9: 458–463.
R. Herring (2010), ‘Epistemic brokerage in the bio-property narrative: contributions to explaining opposition to transgenic technologies in agriculture’, New Biotechnology 27: 614–622.
C.H. King and A.M. Bertino (2008), ‘Asymmetries of poverty: why global burden of disease valuations underestimate the burden of neglected tropical diseases’, PLoS Neglected Tropical Diseases 2: e209.
C. Kolstad (1987), ‘Uniformity versus differentiation in regulating externalities’, Journal of Environmental Economics and Management 14: 386–399.
R. Paarlberg (2008), Starved for Science: How Biotechnology is Being Kept Out of Africa, Cambridge, MA: Harvard University Press.
I. Potrykus (2010a), ‘Regulation must be revolutionized’, Nature 466: 561.
I. Potrykus (2010b), ‘Lessons from the “Humanitarian Golden Rice” project: regulation prevents development of public good genetically engineered crop products’, New Biotechnology 27: 466–472.
M. Qaim , A. Stein, and J.V. Meenakshi (2007), ‘Economics of biofortification’, Agricultural Economics 37(s1): 119–133.
K. Ramessar , A. Peremarti, S. Gomez-Galera, S. Naqvi, M. Moralejo, P. Munoz, T. Capell, and P. Chritou (2007), ‘Biosafety and risk assessment framework for selectable marker genes in transgenic crop plants: a case of the science not supporting the politics’, Transgenic Research 16: 261–280.
M. Richards , R. Hardy, D. Kuh, and M. Wadsworth (2002), ‘Birth weight, postnatal growth and cognitive function in a national UK birth cohort’, International Journal of Epidemiology 31: 342–348.
P. Shewry , M. Baudo, A. Lovegrove, and S. Powers (2007), ‘Are GM and conventionally bred cereals really different?’, Trends in Food Sciences and Technology 18: 201–209.
A. Stein , H. Sachdev, and M. Qaim (2008), ‘Genetic engineering for the poor: Golden Rice and public health in India’, World Development 36: 144–158.
G. Tang , J. Qin, G. Dolnikoawski, R. Russell, and M. Grusak (2009), ‘Golden Rice is an effective source of vitamin A’, American Journal of Clinical Nutrition 89: 1176–1183.
G. Tang , Y. Hu, S. Yin, Y. Wang, G. Dallal, M. Grusak, and R. Russell (2012), ‘β-Carotene in Golden Rice is as good as β-carotene in oil at providing vitamin A to children’, American Journal of Clinical Nutrition 96: 658–664.
H. Taylor and S. Karlin (1984), An Introduction to Stochastic Modeling, Orlando, FL: Academic Press.
H. van den Belt (2003), ‘Debating the precautionary principle: “guilty until proven innocent” or “innocent until proven guilty”?’, Plant Physiology 132: 1122–1126.
M. Vigani and A. Olper (2014), ‘GM-free private standards, public regulation of GM products and mass media’, Environment and Development Economics, this issue.
J. Wesseler , S. Scatasta, and E. Fall (2011), ‘Environmental benefits and costs of GM crops’, in C. Carter, G.C. Moschini, and I. Sheldon (eds), Genetically Modified Food and Global Welfare, Bingley: Emerald Group Publishing, pp. 173–199.
K. West and I. Darnton-Hill (2008), ‘Vitamin A deficiency’, in R.D. Semba and M.W. Bloem (eds), Nutrition and Health in Developing Countries, Totowa, NJ: Humana Press, pp. 377–433.
R. Zimmermann and M. Qaim (2004), ‘Potential health benefits of Golden Rice: a Philippine case study’, Food Policy 29: 147–168.